Skip to main content
. Author manuscript; available in PMC: 2016 Dec 8.
Published in final edited form as: Curr Protoc Pharmacol. 2015 Dec 8;71:1.34.1–1.3421. doi: 10.1002/0471141755.ph0134s71

Table 2.

Sample conversion of total [3H]-(+)-pentazocine counts into nanomolar concentrations in assay

Targeted [3H]-(+)-PTZ concentration (nM) Measured total radioactivity (DPM) Measured total [3H]-(+)-PTZ (mmol) Measured [3H]-(+)-PTZ concentration in assay (nM)
300 2037960 2.70E-08 270.0
100 679420 9.00E-09 90.0
30 204684 2.71E-09 27.1
10 66382 8.79E-10 8.8
3 21047 2.79E-10 2.8
1 6573 8.71E-11 0.9
0.3 2234 2.96E-11 0.3

The first column displays targeted concentrations of [3H]-(+)-pentazocine calculated from the stock vial (34 Ci/mmol or ~29.4 μM). Second column contains radioactivity counts in DPM of the targeted concentration of [3H]-(+)-pentazocine. Third column shows radioactivity values transformed from DPM into millimoles of radioligand (Note: the conversion factor used was 2.22 × 1012 DPM per Ci). The fourth column shows the actual concentrations of [3H]-(+)-pentazocine as calculated from the DPM values obtained.